Mechanistic Insights into Splicing Modulation to Define RNA–Small Molecule Interactions & Unlock Targetable Splice Sequences

• Expanding splice modulation into new RNA sequence contexts to identify novel therapeutic targets
• Decoding how RNA–small molecule interactions drive binding, splice site recognition and modulation mechanisms

Speakers:

Christopher Trotta

Senior Vice President of Discovery Biology

PTC Therapeutics